Global Cognitive Neuroscience Market Size To Exceed USD 75.63 Billion By 2035 | CAGR of 6.56%

Global Cognitive Neuroscience Market Size To Exceed USD 75.63 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global Cognitive Neuroscience Market size is expected to Grow from USD 37.58 Billion in 2024 to USD 75.63 Billion by 2035, at a CAGR of 6.56% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Cognitive Neuroscience Market Size, Share, and COVID-19 Impact Analysis, By Type (Magnetic Resonance Imaging (MRI), Functional Magnetic Resonance Imaging (fMRI), Positron Emission Tomography (PET), Magnetoencephalography (MEG), Encephalography (EEC), Near Infrared Spectroscopy (NIRS), and Single Photon Emission Computed Tomography (SPECT)), By Application (Brain Imaging, Neurological Research, Neurological Disorders and Psychiatry), By End User (Pharmaceutical Companies, Clinical & Research Laboratories, Academic Research Institutes, Hospitals & Pathology Laboratories and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/cognitive-neuroscience-market 

The Cognitive Neuroscience Market Size focuses on understanding brain functions linked to cognition, including memory, perception, attention, decision-making, and language. Integrating psychology, neurology, and neurobiology, it leverages advanced tools such as fMRI, PET, EEG, and brain-computer interfaces (BCIs). These technologies are widely applied in clinical research, mental health assessments, neurodegenerative disease diagnosis, cognitive enhancement, and brain-machine interaction studies. Market growth is propelled by rising neurological and psychiatric disorder prevalence, an ageing population, and demand for innovative diagnostic and therapeutic solutions. Technological innovations such as AI-driven neuroimaging, high-resolution brain mapping, and real-time neural monitoring are expanding insights into brain mechanisms and accelerating translational research. Additionally, increased public and private funding, combined with collaborative research initiatives, fosters innovation in neurotechnology, personalized medicine, early cognitive disorder detection, and neuro-enhancement applications, supporting sustained market expansion. Market growth is restrained by expensive neuroimaging equipment and limited availability in low-income or developing regions.

The magnetic resonance imaging (MRI) segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the cognitive neuroscience market is divided into magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), positron emission tomography (PET), magnetoencephalography (MEG), encephalography (EEC), near infrared spectroscopy (NIRS) and single photon emission computed tomography (SPECT). Among these, the magnetic resonance imaging (MRI) segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Market growth is driven by rising chronic disease prevalence, innovations in MRI technology, and heightened preventive health awareness. Additionally, expanding healthcare infrastructure and government efforts to improve diagnostic capabilities in emerging economies further support market development.

The brain imaging segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the application, the cognitive neuroscience market is divided into brain imaging, neurological research, neurological disorders and psychiatry. Among these, the brain imaging segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Brain imaging’s non-invasive approach and ability to deliver detailed, real-time neural data are vital in cognitive neuroscience, enabling accurate diagnosis and treatment of neurological and psychiatric disorders, including Alzheimer’s, Parkinson’s, schizophrenia, and ADHD.

The academic research institutes segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the cognitive neuroscience market is divided into pharmaceutical companies, clinical & research laboratories, academic research institutes, hospitals & pathology laboratories and others. Among these, the academic research institutes segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The extensive adoption of advanced neuroimaging and brain-mapping technologies in academic and research institutions, along with partnerships with pharmaceutical firms and hospitals for translational studies, significantly drives the demand for cognitive neuroscience instruments and services.

North America is expected to hold the majority share of the global cognitive neuroscience market during the forecast period.

North America is expected to hold the majority share of the global cognitive neuroscience market during the forecast period. Leading academic institutions, research labs, and hospitals in North America are outfitted with advanced neuroimaging and brain-monitoring systems, supporting cutting-edge research in cognition, neurological disorders, and mental health. Rising mental health awareness and increasing neurological conditions further drive demand for sophisticated diagnostic and monitoring technologies.

Asia Pacific is anticipated to grow at the fastest pace in the global cognitive neuroscience market during the forecast period. The growing adoption of cognitive neuroscience tools in clinical diagnostics, education, and consumer wellness is fueled by urbanization, expanding middle-class populations, and rising mental health awareness. Advances in digital health, wearable devices, and AI are making these technologies more accessible and cost-effective.

Major vendors in the global cognitive neuroscience market are Siemens Healthineers, Medtronic, GE Healthcare, Blackrock Neurotech, Philips Healthcare, NeuroPace, Boston Scientific, Neuralink, Compumedics Limited, Alpha Omega Inc., EMOTIV, Cadwell Industries Inc., ANT Neuro, Brain Products GmbH, Nihon Kohden Corporation, and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In September 2025, Siemens Healthineers and Stryker announced a strategic partnership to develop a robotic system for neurovascular procedures, including stroke and aneurysm treatments. Combining Siemens’ expertise in robotics and image-guided therapy with Stryker’s neurovascular technologies, the collaboration focuses on system design, device integration, imaging, and workflow optimization.

• In January 2025, Medtronic announced CE Mark approval in the EU and UK for BrainSense Adaptive DBS and BrainSense Electrode Identifier, meeting EU MDR standards. The first patient programming in Europe, performed at Amsterdam University Medical Centre, marks a major step in personalized Parkinson’s therapy.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the cognitive neuroscience market based on the below-mentioned segments:

Global Cognitive Neuroscience Market, By Type

• Magnetic Resonance Imaging (MRI)
• Functional Magnetic Resonance Imaging (fMRI)
• Positron Emission Tomography (PET)
• Magnetoencephalography (MEG)
• Encephalography (EEC)
• Near Infrared Spectroscopy (NIRS)
• Single Photon Emission Computed Tomography (SPECT)

Global Cognitive Neuroscience Market, By Application

• Brain Imaging
• Neurological Research
• Neurological Disorders
• Psychiatry

Global Cognitive Neuroscience Market, By End User

• Pharmaceutical Companies
• Clinical & Research Laboratories
• Academic Research Institutes
• Hospitals & Pathology Laboratories
• Others

 Global Cognitive Neuroscience Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter